The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer
Condition: Colorectal Neoplasms Intervention: Drug: PD-L1 Monoclonal Antibody Combined With Lenalidomide Sponsor: Lining Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials